Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
Hussain, R; Shahid, F; Zafar, S; Dojki, M; DOCKRELL, HM;
2004
Immunology, (2004).111 4 10.1111/j.0019-2805.2004.01839.x.
Recent advances in pneumococcal vaccination of children.
Russell, FM; MULHOLLAND, EK;
2004
Annals of tropical paediatrics, (2004).24 4 10.1179/027249304225019109.
Rate of first recorded diagnosis of autism and other pervasive developmental disorders in United Kingdom general practice, 1988 to 2001.
SMEETH, L; Cook, C; Fombonne, PE; Heavey, L; RODRIGUES, LC; SMITH, PG; Hall, AJ;
2004
BMC medicine, (2004).2 1 10.1186/1741-7015-2-39.
Communicable diseases in complex emergencies: impact and challenges.
Connolly, MA; Gayer, M; Ryan, MJ; Salama, P; Spiegel, P; HEYMANN, DL;
2004
Lancet, (2004).364 9449 10.1016/S0140-6736(04)17481-3.
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults.
Moorthy, VS; Imoukhuede, EB; MILLIGAN, P; BOJANG, K; Keating, S; Kaye, P; Pinder, M; Gilbert, SC; Walraven, G; GREENWOOD, BM; Hill, AS V;
2004
PLoS medicine, (2004).1 2 10.1371/journal.pmed.0010033.
Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: another view of the evidence.
MANGTANI, P; Hall, AJ; CUTTS, F;
2003
The Lancet infectious diseases, (2003).3 5 10.1016/s1473-3099(03)00605-4.
Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.
Mbopi-Kéou, F-X; Bélec, L; Dalessio, J; Legoff, J; Grésenguet, G; MAYAUD, P; Brown, DW G; Morrow, RA;
2003
Clinical and diagnostic laboratory immunology, (2003).10 3 10.1128/cdli.10.3.388-393.2003.
Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria.
Polley, SD; TETTEH, KK A; Cavanagh, DR; Pearce, RJ; Lloyd, JM; BOJANG, KA; Okenu, DM N; GREENWOOD, BM; McBride, JS; CONWAY, DJ;
2003
Infection and immunity, (2003).71 4 10.1128/IAI.71.4.1833-1842.2003.
Variant Creutzfeldt-Jakob disease: An epidemiological update in relation to geographically associated cases and history of vaccination.
Ward, HJ T; Everington, D; Cousens, S; Gill, N; SMITH, PG; Will, R;
2003
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, (2003).74 3
Measles outbreaks in a population with declining vaccine uptake.
Jansen, VA A; Stollenwerk, N; Jensen, HJ; Ramsay, ME; EDMUNDS, WJ; Rhodes, CJ;
2003
Science (New York, NY), (2003).301 5634 10.1126/science.1086726.